Postoperative weight loss leads to poor survival through poor S-1 efficacy in patients with stage II/III gastric cancer

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial

(2014) Akira Tsuburaya et al.   LANCET ONCOLOGY

The Prognostic Nutritional Index Predicts Long-term Outcomes of Gastric Cancer Patients Independent of Tumor Stage

(2013) Kazuhiro Migita et al.   ANNALS OF SURGICAL ONCOLOGY

Body Weight Loss After Surgery is an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer

(2012) Toru Aoyama et al.   ANNALS OF SURGICAL ONCOLOGY

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

(2012) Yung-Jue Bang et al.   LANCET

Usefulness of enhanced recovery after surgery protocol as compared with conventional perioperative care in gastric surgery

(2011) Takanobu Yamada et al.   Gastric Cancer

Japanese classification of gastric carcinoma: 3rd English edition

(2011)   Gastric Cancer

Japanese gastric cancer treatment guidelines 2010 (ver. 3)

(2011)   Gastric Cancer

Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954

(2010) Christoph Schuhmacher et al.   JOURNAL OF CLINICAL ONCOLOGY

Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) Preserves Lean Body Mass Following Esophageal Cancer Surgery: Results of a Double-Blinded Randomized Controlled Trial

(2009) Aoife M. Ryan et al.   ANNALS OF SURGERY